Hennion & Walsh Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$508K Sell
208,997
-1,829
-0.9% -$4.47K 0.01% 742
2026
Q1
$500K Buy
210,826
+2,485
+1% +$8.61K 0.02% 721
2025
Q4
$1.08M Buy
208,341
+49,601
+31% +$240K 0.04% 497
2025
Q3
$670K Buy
158,740
+65,333
+70% +$304K 0.02% 621
2025
Q2
$342K Buy
+93,407
New +$348K 0.01% 777

Other funds holding ORGO

Hennion & Walsh Asset Management's ORGO Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Organogenesis Holdings (ORGO) stake by 0.87% in Q2 2026, selling an estimated $4.47K and leaving 208,997 shares worth $508K. The position accounts for 0.01% of the portfolio, ranked #742.

Hennion & Walsh Asset Management first reported a position in ORGO in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.08M in Q4 2025. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Hennion & Walsh Asset Management held 208,997 shares of Organogenesis Holdings worth $508K as of Q2 2026.
  • Hennion & Walsh Asset Management sold 1,829 Organogenesis Holdings shares in Q2 2026, an estimated $4.47K.
  • Organogenesis Holdings made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #742 holding.
  • Hennion & Walsh Asset Management first reported a position in Organogenesis Holdings in Q2 2025 and has held it in 5 quarters since.
  • Hennion & Walsh Asset Management's Organogenesis Holdings position peaked at $1.08M in Q4 2025.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.